CN1433421A - 化学方法和中间体 - Google Patents

化学方法和中间体 Download PDF

Info

Publication number
CN1433421A
CN1433421A CN00818735A CN00818735A CN1433421A CN 1433421 A CN1433421 A CN 1433421A CN 00818735 A CN00818735 A CN 00818735A CN 00818735 A CN00818735 A CN 00818735A CN 1433421 A CN1433421 A CN 1433421A
Authority
CN
China
Prior art keywords
group
compound
isoxazole
tetrahydropyridine
difluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00818735A
Other languages
English (en)
Chinese (zh)
Inventor
M·B·格拉维斯托克
K·E·H·瓦尔伦
D·S·恩尼斯
A·C·柯里
D·艾恩格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AG
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1433421A publication Critical patent/CN1433421A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
CN00818735A 1999-12-03 2000-11-28 化学方法和中间体 Pending CN1433421A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9928499.4A GB9928499D0 (en) 1999-12-03 1999-12-03 Chemical processes and intermediates
GB9928499.4 1999-12-03

Publications (1)

Publication Number Publication Date
CN1433421A true CN1433421A (zh) 2003-07-30

Family

ID=10865576

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00818735A Pending CN1433421A (zh) 1999-12-03 2000-11-28 化学方法和中间体

Country Status (22)

Country Link
EP (1) EP1237895A2 (pt)
JP (1) JP2003515539A (pt)
KR (1) KR20020058072A (pt)
CN (1) CN1433421A (pt)
AR (1) AR026700A1 (pt)
AU (1) AU762241B2 (pt)
BG (1) BG106728A (pt)
BR (1) BR0016087A (pt)
CA (1) CA2395052A1 (pt)
CO (1) CO5271712A1 (pt)
CZ (1) CZ20021912A3 (pt)
EE (1) EE200200282A (pt)
GB (1) GB9928499D0 (pt)
HU (1) HUP0204052A2 (pt)
IL (1) IL149641A0 (pt)
IS (1) IS6401A (pt)
MX (1) MXPA02005396A (pt)
NO (1) NO20022605L (pt)
PL (1) PL364762A1 (pt)
SK (1) SK7862002A3 (pt)
WO (1) WO2001040236A2 (pt)
ZA (1) ZA200203876B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101616588B (zh) * 2006-09-25 2013-09-25 沃克哈特研究中心 取代的哌啶子基苯基噁唑烷酮

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113297D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
EP1427711B1 (en) 2001-09-11 2005-07-13 AstraZeneca AB Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
EP1443930A1 (en) 2001-10-25 2004-08-11 AstraZeneca AB Isoxazoline derivatives useful as antimicrobials
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US7473699B2 (en) 2002-02-28 2009-01-06 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents
EP1480975A2 (en) 2002-02-28 2004-12-01 Astrazeneca AB Chemical compounds
US7094900B2 (en) 2002-08-12 2006-08-22 Pharmacia & Upjohn Company Llc N-Aryl-2-oxazolidinones and their derivatives
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
EP1565186B1 (en) 2002-11-21 2006-11-02 Pharmacia & Upjohn Company LLC N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
EP2492264A3 (en) 2003-06-03 2012-12-19 Rib-X Pharmaceuticals, Inc. Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
TW200526649A (en) 2003-12-17 2005-08-16 Rib X Pharmaceuticals Inc Halogenated biaryl heterocyclic compounds and methods of making and using the same
JP5383037B2 (ja) 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法
JP5534497B2 (ja) 2005-06-08 2014-07-02 メリンタ セラピューティクス,インコーポレイテッド トリアゾール類の合成方法
WO2014014845A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1311787A (zh) * 1998-06-05 2001-09-05 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101616588B (zh) * 2006-09-25 2013-09-25 沃克哈特研究中心 取代的哌啶子基苯基噁唑烷酮

Also Published As

Publication number Publication date
WO2001040236A2 (en) 2001-06-07
IL149641A0 (en) 2002-11-10
CZ20021912A3 (cs) 2002-08-14
WO2001040236A3 (en) 2002-05-10
NO20022605L (no) 2002-06-26
JP2003515539A (ja) 2003-05-07
BR0016087A (pt) 2002-08-06
AU762241B2 (en) 2003-06-19
BG106728A (en) 2003-02-28
CO5271712A1 (es) 2003-04-30
EE200200282A (et) 2003-06-16
EP1237895A2 (en) 2002-09-11
MXPA02005396A (es) 2002-11-29
ZA200203876B (en) 2003-08-15
NO20022605D0 (no) 2002-05-31
SK7862002A3 (en) 2003-02-04
KR20020058072A (ko) 2002-07-12
IS6401A (is) 2002-05-28
AU1715601A (en) 2001-06-12
HUP0204052A2 (hu) 2003-03-28
CA2395052A1 (en) 2001-06-07
AR026700A1 (es) 2003-02-26
GB9928499D0 (en) 2000-02-02
PL364762A1 (en) 2004-12-13

Similar Documents

Publication Publication Date Title
CN1433421A (zh) 化学方法和中间体
Ohmori et al. Total synthesis of bryostatin 3
CN1141305C (zh) 生产1,3-氧硫戊环核苷的方法
WO1998022451A1 (fr) Derives taxol
EP1963260A1 (en) Process for the production of ezetimibe and intermediates used in this proces
EP3483161A1 (en) Intermediates used to make entecavir
WO2009140932A2 (en) Method of producing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone
CN1660818A (zh) 制备有机化合物的方法
WO2008106900A1 (en) Method of manufacturing (3r, 4s) -1- (4-fluorophenyl) -3- [ (3s) -3- (4 -fluorophenyl) -3-hydroxypropyl) ] -4- (4-hyd roxyphenyl) -2-azetidinone
Wessig et al. Enantioselective Preparation of (2R)‐and (2S)‐Azetidine‐2‐carboxylic Acids
US20130296558A1 (en) Preparation process of an antiviral drug (entecavir) and intermediates thereof
Díez et al. The use of butane diacetals of glycolic acid as precursors for the synthesis of the phytotoxic calmodulin inhibitor herbarumin II
US6307064B1 (en) Process to prepare taxol
CN110092793B (zh) 山酮素骨架和异噁唑螺环氧化吲哚拼接衍生物及其制备方法及应用
CN1252788A (zh) 制备药用化合物的方法
Wattanasereekul et al. Synthesis of the 8‐Hydroxy Acid of Jasplakinolide
KR20060051371A (ko) 이미다조피란 유도체의 제조방법
CN1181078A (zh) 作为多核苷酸交联剂的非核苷的香豆素衍生物
JP2001500484A (ja) 医薬化合物の製造法
CN1115333C (zh) 生产2-磺酰基吡啶衍生物和生产2-{[(2-吡啶基)甲基]硫基}-1h-苯并咪唑衍生物的方法
JP2000281625A (ja) 光学活性な1−アシルオキシ−3−ヒドロキシ化合物の製造方法
CN114554848A (zh) 用于合成吡啶酰胺的方法
JP4523761B2 (ja) 抗腫瘍活性を有する新規化合物、およびその製造方法
CN1064681A (zh) 制备核苷衍生物的方法
CN1060842A (zh) 新环丁烷衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication